Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
NCT00016523 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 420
Last updated 2017-09-26
Summary
This multicenter trial tested whether inhaled nitric oxide would reduce death or the need for oxygen in preterm infants (less than 34 weeks gestational age) with severe lung disease.
Conditions
Interventions
- DRUG
-
Inhaled nitric oxide
Started at 5 ppm and could be increased to 10 ppm
- DRUG
-
Started at 5 ppm and could be increased to 10 ppm
Sponsors & Collaborators
-
National Center for Research Resources (NCRR)
collaborator NIH -
NICHD Neonatal Research Network
lead NETWORK
Principal Investigators
-
Krisa P. Van Meurs, MD · Stanford University
-
Waldemar A. Carlo, MD · University of Alabama at Birmingham
-
Abbot R. Laptook, MD · Brown University, Women & Infants Hospital of Rhode Island
-
Edward F. Donovan, MD · Children's Hospital Medical Center, Cincinnati
-
James A. Lemons, MD · Indiana University
-
Shahnaz Duara, MD · University of Miami
-
Charles R. Rosenfeld, MD · University of Texas, Southwestern Medical Center at Dallas
-
Jon E. Tyson, MD MPH · The University of Texas Health Science Center, Houston
-
Seetha Shankaran, MD · Wayne State University
-
Richard A. Ehrenkranz, MD · Yale University
-
T. Michael O'Shea, MD MPH · Wake Forest University
-
Neil N. Finer, MD · University of California, San Diego
-
Dale L. Phelps, MD · University of Rochester
-
Mark L. Hudak, MD · University of Florida
-
Robin H. Steinhorn, MD · Northwestern University
-
G. Ganesh Konduri, MD · Medical College of Wisconsin, Milwaukee
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 120 Hours
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-01-31
- Primary Completion
- 2003-09-30
- Completion
- 2006-05-31
Countries
- United States
Study Locations
More Related Trials
-
Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure
NCT01891500 ·Status: WITHDRAWN ·Phase: PHASE4
-
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
NCT00006401 ·Status: COMPLETED ·Phase: PHASE3
-
Prolonged Outcomes After Nitric Oxide (PrONOx)
NCT00234247 ·Status: COMPLETED
-
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
NCT03576885 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
NCT01220687 ·Status: COMPLETED ·Phase: NA
-
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
NCT01503801 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation
NCT00041548 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
NCT00551642 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
NCT00931632 ·Status: COMPLETED ·Phase: PHASE3
-
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn
NCT00139217 ·Status: COMPLETED ·Phase: NA
-
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
NCT01467076 ·Status: TERMINATED ·Phase: PHASE2
-
Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension
NCT07099144 ·Status: RECRUITING
-
Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension
NCT03132428 ·Status: TERMINATED
-
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04264156 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics
NCT00041561 ·Status: TERMINATED ·Phase: PHASE3
-
Predictors of Inhaled Nitric Oxide Responsiveness in Patients With PPHN
NCT06043635 ·Status: WITHDRAWN
-
Inhaled NO in Prevention of Chronic Lung Disease
NCT00000548 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
NCT00598429 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nasal High Frequency Ventilation in Preterm Infants: A Pilot Study
NCT00296231 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
NCT00569530 ·Status: COMPLETED ·Phase: PHASE3
-
Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
NCT02528318 ·Status: TERMINATED ·Phase: PHASE2
-
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome
NCT06690801 ·Status: RECRUITING
-
Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
NCT01022580 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Therapy in VLBW Infants at Risk of CLD
NCT00011362 ·Status: COMPLETED ·Phase: PHASE3
-
Heliox in Preterm Infants With Respiratory Distress Syndrome
NCT01759316 ·Status: COMPLETED ·Phase: NA